Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Sex differences in major depression and comorbidity of cardiometabolic disorders: impact of prenatal stress and immune exposures.

Goldstein JM, Hale T, Foster SL, Tobet SA, Handa RJ.

Neuropsychopharmacology. 2018 Jul 7. doi: 10.1038/s41386-018-0146-1. [Epub ahead of print] Review.

PMID:
30030541
2.

Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.

Boal AH, Smith DJ, McCallum L, Muir S, Touyz RM, Dominiczak AF, Padmanabhan S.

Hypertension. 2016 Nov;68(5):1132-1138. Epub 2016 Oct 10.

3.

The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort.

Zettergren A, Kern S, Gustafson D, Gudmundsson P, Sigström R, Östling S, Eriksson E, Zetterberg H, Blennow K, Skoog I.

Am J Geriatr Psychiatry. 2017 Feb;25(2):170-177. doi: 10.1016/j.jagp.2016.06.009. Epub 2016 Jun 23.

PMID:
27639288
4.

[Primary and secondary arterial hypertension - update 2016].

Sanner B, Hausberg M.

Dtsch Med Wochenschr. 2016 Jun;141(11):786-9. doi: 10.1055/s-0042-103976. Epub 2016 Jun 2. German.

PMID:
27254628
5.

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.

Stelzhammer V, Haenisch F, Chan MK, Cooper JD, Steiner J, Steeb H, Martins-de-Souza D, Rahmoune H, Guest PC, Bahn S.

Int J Neuropsychopharmacol. 2014 Oct;17(10):1599-608. doi: 10.1017/S1461145714000819. Epub 2014 Jun 5.

PMID:
24901538
6.

Guideline-directed medical therapy for secondary prevention after coronary artery bypass grafting in patients with depression.

Stenman M, Holzmann MJ, Sartipy U.

Int J Cardiol Heart Vessel. 2014 Mar 6;3:37-42. doi: 10.1016/j.ijchv.2014.02.005. eCollection 2014 Jun.

7.

Predictors of discordance between physicians' and patients' appraisals of health-related quality of life in atrial fibrillation patients: findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial.

von Eisenhart Rothe A, Bielitzer M, Meinertz T, Limbourg T, Ladwig KH, Goette A.

Am Heart J. 2013 Sep;166(3):589-96. doi: 10.1016/j.ahj.2013.05.020. Epub 2013 Jul 10.

PMID:
24016511
8.

Gene environment interaction studies in depression and suicidal behavior: An update.

Mandelli L, Serretti A.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 1):2375-97. doi: 10.1016/j.neubiorev.2013.07.011. Epub 2013 Jul 22. Review.

PMID:
23886513
9.

Aldosterone synergizes with peripheral inflammation to induce brain IL-1β expression and depressive-like effects.

Bay-Richter C, Hallberg L, Ventorp F, Janelidze S, Brundin L.

Cytokine. 2012 Dec;60(3):749-54. doi: 10.1016/j.cyto.2012.08.016. Epub 2012 Sep 13.

PMID:
22981168
10.

AGTR1 gene variation: association with depression and frontotemporal morphology.

Taylor WD, Benjamin S, McQuoid DR, Payne ME, Krishnan RR, MacFall JR, Ashley-Koch A.

Psychiatry Res. 2012 May 31;202(2):104-9. doi: 10.1016/j.pscychresns.2012.03.007. Epub 2012 Jun 15.

11.

Fiber tract-specific white matter lesion severity Findings in late-life depression and by AGTR1 A1166C genotype.

Taylor WD, Zhao Z, Ashley-Koch A, Payne ME, Steffens DC, Krishnan RR, Hauser E, MacFall JR.

Hum Brain Mapp. 2013 Feb;34(2):295-303. doi: 10.1002/hbm.21445. Epub 2011 Oct 22.

12.

No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment.

Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Kessing LV.

Eur Neuropsychopharmacol. 2010 May;20(5):327-35. doi: 10.1016/j.euroneuro.2009.11.004.

PMID:
20022223
13.

Interaction between genetic polymorphisms and stressful life events in first episode depression.

Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Vedel Kessing L.

J Affect Disord. 2009 Dec;119(1-3):107-15. doi: 10.1016/j.jad.2009.02.023. Epub 2009 Mar 31.

PMID:
19339052
14.

Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression.

Tousoulis D, Antoniades C, Drolias A, Stefanadi E, Marinou K, Vasiliadou C, Tsioufis C, Toutouzas K, Latsios G, Stefanadis C.

J Card Fail. 2008 Aug;14(6):456-64. doi: 10.1016/j.cardfail.2008.02.015. Epub 2008 May 27.

PMID:
18672192
15.

Association of AGTR1 with 18-month treatment outcome in late-life depression.

Kondo DG, Speer MC, Krishnan KR, McQuoid DR, Slifer SH, Pieper CF, Billups AV, Steffens DC.

Am J Geriatr Psychiatry. 2007 Jul;15(7):564-72.

PMID:
17586781
16.

Renin-angiotensin-system gene polymorphisms and depression.

Saab YB, Gard PR, Yeoman MS, Mfarrej B, El-Moalem H, Ingram MJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1113-8. Epub 2007 Apr 6.

PMID:
17499413
17.

Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors.

Malinin AI, Ong S, Makarov LM, Petukhova EY, Serebruany VL.

Int J Clin Pract. 2006 Aug;60(8):993-1002. Review.

PMID:
16893441
18.

Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness.

Kreyenbuhl J, Dickerson FB, Medoff DR, Brown CH, Goldberg RW, Fang L, Wohlheiter K, Mittal LP, Dixon LB.

J Nerv Ment Dis. 2006 Jun;194(6):404-10.

19.

Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders.

Mendlewicz J, Oswald P, Claes S, Massat I, Souery D, Van Broeckhoven C, Del-Favero J.

Int J Neuropsychopharmacol. 2005 Dec;8(4):505-13. Epub 2005 Jun 1.

PMID:
15927090
20.

Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression.

Gard PR.

Expert Opin Ther Targets. 2004 Feb;8(1):7-14. Review.

PMID:
14996614

Supplemental Content

Loading ...
Support Center